You are here

MacroGenics Announces Date of Fourth Quarter and Full Year 2018 Financial Results Conference Call

ROCKVILLE, MD, Feb. 19, 2019 (GLOBE NEWSWIRE) --  MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today announced that on Tuesday, February 26, 2019, the Company will release its financial results for the fourth quarter and full year 2018. The Company's management team will host a conference call discussing the Company's financial results and recent corporate developments on Tuesday, February 26, 2019 at 4:30 pm ET. The call can be accessed by dialing (877) 303-6253 (domestic) or (973) 409-9610 (international) five minutes prior to the start of the call and providing the passcode 4399964.
Tuesday, February 19, 2019 - 18:36